Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Gastroenterological Surgery
  •  Endocrine Surgery
  •  General Surgery
  •  Bariatric Surgery
  •  Robotic Surgery
  •  Surgical Oncology
  •  Minimally Invasive Surgery
  •  Neurological Surgery


Citation: Clin Surg. 2020;5(1):2705.Research Article | Open Access

A Retrospective Study to Investigate the Clinical Performance and Safety of BMI CSF Shunting System in Patients Who Needed Cerebrospinal Fluid Drainage Therapy

Chieh-Tsai Wu*, Hsiu-Ling Chang, Chen-Ying Liu and Po-Chuan Hsieh

Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taiwan, China

*Correspondance to: Chieh-Tsai Wu 

 PDF  Full Text DOI: 10.25107/2474-1647.2705


Background: Despite BMI Cerebrospinal Fluid (CSF) Shunting System has been on the market for decades, no studies have been carried out. This retrospective study examined its clinical performance and safety, and attempted to discern risk factors. Methods: Medical records from 232 patients with External Ventricular Drainage (EVD) placement and 35 patients with Ventriculoperitoneal (VP) shunt placement were reviewed for 1 year and 2 years postoperatively, respectively. Results: The incidence of device malfunction was 22.9% for VP shunt in 2 years and 25.4% for EVD in 1 year. The most common cause of device malfunction was over drainage for VP shunt; and distal displacement and infection for EVD. The incidence of complications was 2.9% in the VP shunt group and 27.6% in the EVD group, while that of device-related infections were 0.0% and 7.3%, respectively. No one in the VP shunt died in 2 years postoperatively, while 2 patients (0.9%) in the EVD group died in 1 year postoperatively. No factors were found to influence the VP shunt survival; while age, catheter diameter, type of hydrocephalus, and Glasgow Coma Scale (GCS) score before surgery were found to have significant impact on EVD function. Conclusion: Compared to other similar device, BMI EVD showed comparable clinical performance and VP shunt showed superior clinical performance. Both devices were safe, with limited devicerelated infections reported. Our study sheds some light on the long-term outcome of BMI CSF Shunting System. Further study on a larger population is warranted to verify the predictors of device survival we identified in this analysis.


BMI CSF Shunting System; Hydrocephalus; Clinical performance; Safety; Retrospective

Cite the article

Wu C-T, Chang H-L, Liu C-Y, Hsieh P-C. A Retrospective Study to Investigate the Clinical Performance and Safety of BMI CSF Shunting System in Patients Who Needed Cerebrospinal Fluid Drainage Therapy. Clin Surg. 2020; 5: 2705..

Search Our Journal

Journal Indexed In

Articles in PubMed

RAF Kinase Inhibitory Protein Expression and Phosphorylation Profiles in Oral Cancers
 PubMed  PMC  PDF  Full Text
Antimicrobial Peptides: A Potential Therapeutic Option for Surgical Site Infections
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

The Role Exosomes Played on Pancreatic Cancer
 Abstract  PDF  Full Text
Sclerotherapy with Polidocanol Foam is a Promising Perspective Treatment for Pyogenic Granuloma: A Retrospective Analysis in 52 Cases
 Abstract  PDF  Full Text
View More...